ClinicalTrials.Veeva

Menu

Anthropometric Measures and Severity of Gastroesophageal Reflux Disease

A

Ain Shams University

Status

Completed

Conditions

Gastroesophageal Reflux Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01954667
Anthropometric Measures &GERD

Details and patient eligibility

About

evaluate the impact of different anthropometric measures on clinical and endoscopic severity of GERD and its relation to serum leptin.

Enrollment

80 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Gastro esophageal reflux symptoms (e.g. heart burn, regurgitation, water brash or atypical symptoms such as hoarseness of voice, asthma and cough)
  • complete upper gastrointestinal endoscopy.

Exclusion criteria

  • Receiving medication for reflux disease (including proton pump inhibitor, histamine type 2 receptors blocker, prokinetic agents) in the previous month.
  • Pregnant woman.
  • History of upper abdominal surgery.
  • Severe co-morbidity as cirrhosis, end-stage renal disease and heart failure.

Trial design

80 participants in 3 patient groups

obese and overweight
Description:
Group1 (n=30): overweight and obese (BMI ≥25 and/ or WHtR≥0.5)
average body weight
Description:
Group2 (n=30): normal weight (BMI ≥ 18 to \< 25 and/or WHtR ≥0.4 to \<0.5)
Control group
Description:
Control Group (n= 20): healthy subjects, matched for age and gender, were included in this study. All included controls had average weight (BMI ≥ 18 to \< 25 and/ or WHtR ≥0.4 to \<0.5)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems